Global Blood Transfusion Diagnostics Market 2022-2028
Description
Global Blood Transfusion Diagnostics Market 2022-2028
The global blood transfusion diagnostics market is projected to rise by USD 1.9 billion by 2028, according to a new report by Gen Consulting Company. It is anticipated to expand at a CAGR of 6.7 percent during the forecast period.
The report covers market size and growth, segmentation, regional breakdowns, competitive landscape, trends and strategies for global blood transfusion diagnostics market. It traces the market’s historic and forecast market growth. The report identifies top segments for opportunities and strategies based on market trends and leading competitors’ approaches. This study also provides an analysis of the impact of the COVID-19 crisis on the blood transfusion diagnostics industry.
This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the product, application, end user, and region. The global market for blood transfusion diagnostics can be segmented by product: reagent and kit, instrument, others. Among these, the reagent and kit segment was accounted for the highest revenue generator in 2021. Blood transfusion diagnostics market is further segmented by application: blood grouping, disease screening, others. The disease screening segment is estimated to account for the largest share of the global blood transfusion diagnostics market. Based on end user, the blood transfusion diagnostics market is segmented into: hospital, blood bank, diagnostic laboratory, others. The blood bank segment held the largest share of the global blood transfusion diagnostics market in 2021 and is anticipated to hold its share during the forecast period. On the basis of region, the blood transfusion diagnostics market also can be divided into: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America. In 2021, North America made up the largest share of revenue generated by the blood transfusion diagnostics market.
Market Segmentation
By product: reagent and kit, instrument, others
By application: blood grouping, disease screening, others
By end user: hospital, blood bank, diagnostic laboratory, others
By region: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America
The report has also analysed the competitive landscape of the global blood transfusion diagnostics market with some of the key players being Abbott Laboratories, BAG Health Care GmbH, Beckman Coulter, Inc., Bio-Rad Laboratories, Inc., DiaSorin S.p.A., Hoffmann-La Roche Ltd., Ortho Clinical Diagnostics, Inc., Quotient Limited, Werfen, S.A., among others.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
Historical & Forecast Period
This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.
Scope of the Report
The global blood transfusion diagnostics market is projected to rise by USD 1.9 billion by 2028, according to a new report by Gen Consulting Company. It is anticipated to expand at a CAGR of 6.7 percent during the forecast period.
The report covers market size and growth, segmentation, regional breakdowns, competitive landscape, trends and strategies for global blood transfusion diagnostics market. It traces the market’s historic and forecast market growth. The report identifies top segments for opportunities and strategies based on market trends and leading competitors’ approaches. This study also provides an analysis of the impact of the COVID-19 crisis on the blood transfusion diagnostics industry.
This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the product, application, end user, and region. The global market for blood transfusion diagnostics can be segmented by product: reagent and kit, instrument, others. Among these, the reagent and kit segment was accounted for the highest revenue generator in 2021. Blood transfusion diagnostics market is further segmented by application: blood grouping, disease screening, others. The disease screening segment is estimated to account for the largest share of the global blood transfusion diagnostics market. Based on end user, the blood transfusion diagnostics market is segmented into: hospital, blood bank, diagnostic laboratory, others. The blood bank segment held the largest share of the global blood transfusion diagnostics market in 2021 and is anticipated to hold its share during the forecast period. On the basis of region, the blood transfusion diagnostics market also can be divided into: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America. In 2021, North America made up the largest share of revenue generated by the blood transfusion diagnostics market.
Market Segmentation
By product: reagent and kit, instrument, others
By application: blood grouping, disease screening, others
By end user: hospital, blood bank, diagnostic laboratory, others
By region: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America
The report has also analysed the competitive landscape of the global blood transfusion diagnostics market with some of the key players being Abbott Laboratories, BAG Health Care GmbH, Beckman Coulter, Inc., Bio-Rad Laboratories, Inc., DiaSorin S.p.A., Hoffmann-La Roche Ltd., Ortho Clinical Diagnostics, Inc., Quotient Limited, Werfen, S.A., among others.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
Historical & Forecast Period
This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.
Scope of the Report
- To analyze and forecast the market size of the global blood transfusion diagnostics market.
- To classify and forecast the global blood transfusion diagnostics market based on product, application, end user, region.
- To identify drivers and challenges for the global blood transfusion diagnostics market.
- To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global blood transfusion diagnostics market.
- To identify and analyze the profile of leading players operating in the global blood transfusion diagnostics market.
- Gain a reliable outlook of the global blood transfusion diagnostics market forecasts from 2022 to 2028 across scenarios.
- Identify growth segments for investment.
- Stay ahead of competitors through company profiles and market data.
- The market estimate for ease of analysis across scenarios in Excel format.
- Strategy consulting and research support for three months.
- Print authentication provided for the single-user license.
Table of Contents
73 Pages
- PART 1. INTRODUCTION
- Report description
- Objectives of the study
- Market segment
- Years considered for the report
- Currency
- Key target audience
- PART 2. METHODOLOGY
- PART 3. EXECUTIVE SUMMARY
- PART 4. MARKET OVERVIEW
- Introduction
- Drivers
- Restraints
- Impact of COVID-19 pandemic
- PART 5. MARKET BREAKDOWN BY PRODUCT
- Reagent and kit
- Instrument
- Others
- PART 6. MARKET BREAKDOWN BY APPLICATION
- Blood grouping
- Disease screening
- Others
- PART 7. MARKET BREAKDOWN BY END USER
- Hospital
- Blood bank
- Diagnostic laboratory
- Others
- PART 8. MARKET BREAKDOWN BY REGION
- North America
- Europe
- Asia-Pacific
- MEA (Middle East and Africa)
- Latin America
- PART 9. KEY COMPANIES
- Abbott Laboratories
- BAG Health Care GmbH
- Beckman Coulter, Inc.
- Bio-Rad Laboratories, Inc.
- DiaSorin S.p.A.
- Hoffmann-La Roche Ltd.
- Ortho Clinical Diagnostics, Inc.
- Quotient Limited
- Werfen, S.A.
- *REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
- DISCLAIMER
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
